- Show all
- Abigail Coursolle
- Brian Brooks
- Fabiola Carrión
- Amy Chen
- daryln
- Corey Davis
- Andrew DiAntonio
- Elizabeth Edwards
- Candace Gibson
- Sarah Grusin
- Héctor Hernández-Delgado
- Rachel Holtzman
- Priscilla Huang
- Alicia Kauk
- Jennifer Lav
- Leonardo Cuello
- Jeremy Leaming
- Kimberly Lewis
- lhigashi
- David Machledt
- Elizabeth McCaman
- Catherine McKee
- Joe McLean
- Michelle Lilienfeld
- National Health Law Program Team
- Hayley Penan
- Jane Perkins
- Alexis Robles
- Susan Berke Fogel
- Sarah Somers
- Elizabeth G. Taylor
- veng
- Wayne Turner
- Mara Youdelman
- Show all
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Maine
- Maryland
- Massachusetts
- Michigan
- Mississippi
- Missouri
- Montana
- National
- New Hampshire
- New Mexico
- New York
- North Carolina
- Oklahoma
- Oregon
- Pennsylvania
- Tennessee
- Texas
- Utah
- Virginia
- Washington
- Show all
- 50th Anniversary
- Abortion
- Affordable Care Act
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Cost-sharing
- Court Access
- Data Collection
- Defending Medicaid
- Demonstrations
- Disability Rights
- Dual Eligible Beneficiaries
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medicaid
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Public Health
- Reproductive Health
- Services
- Supreme Court
- Waivers and Demonstrations
- Women's Health
Archives
- April 8, 2019
National Health Law Program Comments on HHS Safe Harbor Rule for Outpatient Prescription Drugs
Read moreThe U.S. Department of Health and Human Services (HHS) proposed new regulations that would remove safe harbor protections for prescription drug rebates. Currently, rebates paid by manufacturers to Medicare Part D plans and Medicaid managed care organizations (MCOs), including pharmacy benefit managers (PBMs) are shielded from federal anti-kickback laws.…
- March 26, 2019
Request for Information Regarding Grandfathered Group Health Plans and Grandfathered Group Health Insurance Coverage
Read moreThe Affordable Care Act (ACA) allows insurers to phase-in compliance with new consumer protections. Insurer plans with “grandfathered” status are exempt from ACA requirements, such as Essential Health Benefits and no cost preventive screenings and services. But in a recently released "Request for Information (RFI)," the Trump administration is…
- February 19, 2019
Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2020
Read moreNational Health Law Program's comments to the U.S. Department of Health and Human Services (HHS) regarding proposed regulations that would continue the administration's campaign to weaken the landmark Affordable Care Act's protections for health care consumers.
- January 16, 2019
National Health Law Program Comments Regarding Proposed Rule Changes on Medicaid Managed Care and CHIP
Read moreThe National Health Law Program in comments to the U.S. Department of Health and Human Services urges it to reject several proposed changes to Medicaid Managed Care and the Children's Health Insurance Program (CHIP) that would weaken oversight of managed care setups, undermine current standards ensuring access to care…
- January 9, 2019
National Health Law Program Comments: Urge CMS to Reject Proposed Changes to Affordable Care Act
Read moreThe National Health Law Program in comments to HHS urge it to reject the Trump administration's proposed rule change to the Affordable Care Act, called "Patient Protection and Affordable Care Act; Exchange Program Integrity NPRM." The comments outline why Trump's proposed changes to the ACA is yet another attempt…
- December 21, 2018
Comments Urging HIV Prevention Drug be Designated an ACA “A” Recommended Service
Read morePeople who are at risk for HIV can prevent infection by taking a daily medication - Pre Exposure Prophylaxis (PrEP). However, many cannot access PrEP due to its high cost. The Affordable Care Act (ACA) recognizes that even small investments in preventive screenings and services can yield significant cost…